-
US removing 700 immigration officers from Minnesota
-
Who is behind the killing of late ruler Gaddafi's son, and why now?
-
Coach Thioune tasked with saving battling Bremen
-
Russia vows to act 'responsibly' once nuclear pact with US ends
-
Son of Norway's crown princess admits excesses but denies rape
-
US calls for minerals trade zone in rare move with allies
-
Vowles dismisses Williams 2026 title hopes as 'not realistic'
-
'Dinosaur' Glenn chasing skating gold in first Olympics
-
Gaza health officials say strikes kill 23 after Israel says shots wounded officer
-
Italy foils Russian cyberattacks targeting Olympics
-
Stocks stabilise after Wall St AI-fuelled sell-off
-
Figure skating favourite Malinin feeling 'the pressure' in Milan
-
Netflix film probes conviction of UK baby killer nurse
-
Timber hopes League Cup can be catalyst for Arsenal success
-
China calls EU 'discriminatory' over probe into energy giant Goldwind
-
Sales warning slams Ozempic maker Novo Nordisk's stock
-
Can Vonn defy ACL rupture to win Olympic medal?
-
Breakthrough or prelude to attack? What we know about Iran-US talks
-
German far-right MP detained over alleged Belarus sanctions breach
-
MSF says its hospital in South Sudan hit by government air strike
-
Merz heads to Gulf as Germany looks to diversify trade ties
-
Selection process for future Olympic hosts set for reform
-
Serbian minister on trial over Trump-linked hotel plan
-
UK PM says Mandelson 'lied', regrets appointing him US envoy
-
Cochran-Siegle tops first Olympic downhill training
-
Gaza health officials say strikes kill 21 after Israel says shots wounded officer
-
Injured Vonn's Olympic bid is 'inspirational', ski stars say
-
Albania arrests 20 for toxic waste trafficking
-
US-Africa trade deal renewal only 'temporary breather'
-
Mir sets pace on Sepang day two, Yamaha absent
-
Xi, Putin hail 'stabilising' China-Russia alliance
-
GSK boosted by specialty drugs, end to Zantac fallout
-
UK's ex-prince leaves Windsor home amid Epstein storm: reports
-
Sky is the limit for Ireland fly-half Prendergast, says captain Doris
-
Stocks fluctuate after Wall St AI-fuelled sell-off
-
Feyi-Waboso reminds England great Robinson of himself
-
Starmer faces MPs as pressure grows over Mandelson scandal
-
HRW urges pushback against 'aggressive superpowers'
-
Russia demands Ukraine give in as UAE talks open
-
Gaza civil defence says 17 killed in strikes after Israel says shots wounded officer
-
France's Kante joins Fenerbahce after Erdogan 'support'
-
CK Hutchison launches arbitration over Panama Canal port ruling
-
Stocks mostly rise as traders ignore AI-fuelled sell-off on Wall St
-
Acclaimed Iraqi film explores Saddam Hussein's absurd birthday rituals
-
On rare earth supply, Trump for once seeks allies
-
Ukrainian chasing sumo greatness after meteoric rise
-
Draper to make long-awaited return in Davis Cup qualifier
-
Can Ilia Malinin fulfil his promise at the Winter Olympics?
-
CK Hutchison begins arbitration against Panama over annulled canal contract
-
UNESCO recognition inspires hope in Afghan artist's city
Medical Care Technologies (OTC Pink:MDCE) Secures Access to One of the World's Largest Public Skin Cancer Image Databases to Accelerate AI Development
MESA, ARIZONA / ACCESS Newswire / October 1, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), an emerging developer of advanced healthcare AI solutions, today announced that it has secured access to the International Skin Imaging Collaboration (ISIC) Archive - one of the world's largest publicly available, biopsy-verified image repositories for skin cancer and related dermatological conditions.

The ISIC Archive contains more than 70,000 high-quality, expertly annotated dermoscopic images, representing a wide range of skin tones, cancer subtypes, and benign conditions. This unprecedented data resource will serve as a foundation for training MDCE's proprietary AI software designed to detect and classify melanoma and other skin cancers at a level approaching clinical accuracy.
"The medical AI community has long recognized the ISIC Archive as a gold standard for dermatology research," said Marshall Perkins III, CEO of Medical Care Technologies. "By leveraging this highly respected and globally validated dataset, MDCE is advancing its mission to make early detection of skin cancer faster, more accurate, and more accessible worldwide."
Skin cancer is the most common cancer globally, with more than 1.5 million new cases diagnosed each year. Early detection dramatically improves patient outcomes, but access to dermatologists and specialized diagnostic tools remains limited in many parts of the world.
MDCE's development program is currently focused on integrating the ISIC data into its machine learning pipeline, with additional collaborations under review to further expand the diversity and scope of training images.
This milestone positions Medical Care Technologies to progress toward future clinical trials, regulatory pathways, and eventual commercialization of its AI-driven diagnostic platform.
Company Website: www.medicalcaretechnologies.com
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC Pink:MDCE) is a healthcare technology company dedicated to developing innovative medical software solutions that improve early disease detection and patient care outcomes. The company is currently advancing an artificial intelligence platform for skin cancer and dermatological condition identification.
Safe Harbor Statement
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations, projections, and assumptions that involve risks and uncertainties which may cause actual results to differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release.
Contact:
Investor Relations
Medical Care Technologies Inc.
[email protected]
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
D.Johnson--AT